Premium Nahrungsergänzungsmittel | artgerecht

Trimethoprim: Uses, Mechanism and Side Effects

Trimethoprim is an antibacterial medication primarily used to treat urinary tract infections. It works by inhibiting bacterial folic acid synthesis, producing a bacteriostatic effect.

Regular tips about health Regular tips about health

Things worth knowing about "Trimethoprim"

Trimethoprim is an antibacterial medication primarily used to treat urinary tract infections. It works by inhibiting bacterial folic acid synthesis, producing a bacteriostatic effect.

What is Trimethoprim?

Trimethoprim (abbreviated TMP) is a synthetic antibiotic belonging to the diaminopyrimidine class. It is primarily used to treat urinary tract infections (UTIs) and can be administered alone or in combination with sulfamethoxazole (as co-trimoxazol, commonly known as TMP-SMX or cotrimoxazole). Trimethoprim is active against a broad range of gram-positive and gram-negative bacteria.

Indications

Trimethoprim is used in the treatment of:

Uncomplicated urinary tract infections (e.g., cystitis, bladder infections) in adults and children
Acute otitis media (middle ear infection) in children, usually in combination with sulfamethoxazole
Acute exacerbations of chronic bronchitis (in combination)
Pneumocystis jirovecii pneumonia (PCP) – prophylaxis and treatment, especially in immunocompromised patients (in combination with sulfamethoxazole)
Traveler's diarrhea and certain gastrointestinal infections (in combination)

Mechanism of Action

Trimethoprim selectively inhibits the bacterial enzyme dihydrofolate reductase (DHFR). This enzyme is essential for converting dihydrofolate into its active form, tetrahydrofolate, which is required for the synthesis of DNA building blocks (purines and thymidylate).

By blocking this enzyme, trimethoprim disrupts folic acid synthesis within the bacterial cell, preventing bacterial replication. The effect is therefore bacteriostatic (growth-inhibiting). Because human DHFR has a structurally different active site, trimethoprim is largely harmless to humans at therapeutic doses.

When combined with sulfamethoxazole (a sulfonamide), a synergistic effect is achieved: both agents target different steps of the folic acid synthesis pathway, resulting in a bactericidal (bacteria-killing) effect.

Dosage and Administration

Dosage depends on the indication, age, and renal function of the patient. General guidelines for adults include:

Urinary tract infections: 200 mg twice daily or 100 mg three times daily for 7 days
Prophylaxis of recurrent UTIs: 100 mg once daily (long-term prophylaxis)
Dose adjustment is required in patients with reduced kidney function

Trimethoprim is available as tablets or oral suspension. It is taken orally and is well absorbed from the gastrointestinal tract.

Side Effects

Trimethoprim is generally well tolerated. Possible side effects include:

Common: Nausea, vomiting, skin rash, itching
Occasional: Elevated serum creatinine levels (due to inhibition of tubular creatinine secretion, without true kidney damage), hyperkalemia (elevated blood potassium levels)
Rare: Blood count abnormalities (megaloblastic anemia, leukopenia, thrombocytopenia) due to interference with folate metabolism
Very rare: Severe skin reactions (Stevens-Johnson syndrome), liver function disorders

Contraindications and Drug Interactions

Trimethoprim should not be used in patients with:

Known hypersensitivity to trimethoprim
Severe renal impairment (without appropriate dose adjustment)
Megaloblastic anemia due to folate deficiency

Important drug interactions include:

Methotrexate: Increased risk of bone marrow suppression
Warfarin and other anticoagulants: Possible enhancement of anticoagulant effect
ACE inhibitors and potassium-sparing diuretics: Increased risk of hyperkalemia
Phenytoin: Possible increase in phenytoin plasma levels

Antibiotic Resistance

Growing antibiotic resistance is a significant concern with trimethoprim. Resistance commonly arises through mutations in the DHFR gene or through plasmid-mediated resistance genes. In some regions, up to 20-30% of E. coli strains (the most frequent causative agent of UTIs) are resistant to trimethoprim. Therefore, especially in recurrent infections, a susceptibility test (antibiogram) should be performed before starting treatment.

References

World Health Organization (WHO): WHO Model List of Essential Medicines, 23rd Edition. Geneva: WHO, 2023. www.who.int
Brunton, L. L. et al. - Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 13th Edition. McGraw-Hill Education, 2017.
Gupta, K. et al. - Infectious Diseases Society of America (IDSA): Clinical Practice Guideline for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clinical Infectious Diseases, 2011; 52(5): e103-e120.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.